Abstract
The management of patients with primary intracranial germ cell tumors is evolving. There is attention to minimizing late effects of therapy and preserving curability in those patients with pure germinomas and in intensifying chemotherapy for patients with nongerminoma germ cell tumors in an attempt to prolong disease-free survival.
MeSH terms
-
Brain Neoplasms / drug therapy
-
Brain Neoplasms / mortality
-
Brain Neoplasms / pathology
-
Brain Neoplasms / surgery*
-
Child
-
Humans
-
Neoplasm Staging
-
Neoplasms, Germ Cell and Embryonal / drug therapy
-
Neoplasms, Germ Cell and Embryonal / mortality
-
Neoplasms, Germ Cell and Embryonal / pathology
-
Neoplasms, Germ Cell and Embryonal / surgery*
-
Pineal Gland / pathology
-
Pineal Gland / surgery
-
Prognosis
-
Survival Rate